GRCh38/hg38 19p13.2(chr19:11116093-11116999)x1 AND Hypercholesterolemia, familial, 1

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Jan 2, 2018
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000660727.3

Allele description [Variation Report for GRCh38/hg38 19p13.2(chr19:11116093-11116999)x1]

GRCh38/hg38 19p13.2(chr19:11116093-11116999)x1

Gene:

LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]

Variant type:

copy number loss

Cytogenetic location:

19p13.2

Genomic location:

Preferred name:

GRCh38/hg38 19p13.2(chr19:11116093-11116999)x1

HGVS:

NC_000019.10:g.11116093_11116999del

Condition(s)

Name:: Hypercholesterolemia, familial, 1
Synonyms:: LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Clear Turn Off Turn On

protein kinase C, delta, isoform CRA_a [Rattus norvegicus]
protein kinase C, delta, isoform CRA_a [Rattus norvegicus]
gi|149034218|gb|EDL88988.1||gnl|WGS |rCP21327

Protein
ID2B inhibitor of DNA binding 2B (pseudogene) [Homo sapiens]
ID2B inhibitor of DNA binding 2B (pseudogene) [Homo sapiens]
Gene ID:84099

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000782957	Robarts Research Institute, Western University	criteria provided, single submitter (ACMG Guidelines, 2015)	Pathogenic (Jan 2, 2018)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000782957

Robarts Research Institute, Western University

criteria provided, single submitter

(ACMG Guidelines, 2015)

Pathogenic
(Jan 2, 2018)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Robarts Research Institute, Western University, SCV000782957.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Aug 5, 2023

ClinVar

Relating variation to medicine